Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

BXT-51072 in phase I clinical trials

Aug. 16, 1996

U.S. patent reinforces OraVax's UreAB development position

Aug. 16, 1996

Novopharm states intention to market generic ranitidine

Aug. 16, 1996

Glaxo Wellcome fights Novopharm attempt to market generic ranitidine

Aug. 16, 1996

Canadian researchers report GLP-2's potential as digestive disease treatment

Aug. 9, 1996

Astra reports gastrin secretion inhibitors

Aug. 9, 1996

CL-316243: Claimed as gastrointestinal disorders treatment by Glaxo Wellcome

July 26, 1996

Anti-H. pylori compound from Toyama

July 26, 1996

Thiophene and thiophene derivatives described by Sankyo as ulcer treatment

July 26, 1996

Anti-H. pylori cephem compounds described by Fujisawa

July 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...